Vanguard Group’s Incannex Healthcare IXHL Stock Holding History

Vanguard Group’s Portfolio IXHL Stock Details IXHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,802	Closed	-$529K	–	4467
2023 Q4	$529K	Buy	+3,802	New	+$496K	﹤0.01%	4012

Other funds holding IXHL

Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Vanguard Group's IXHL Position: Q1 2024 in Review

Vanguard Group sold out of Incannex Healthcare (IXHL) in Q1 2024, closing a stake of 3,802 shares — an estimated $529K sold.

Vanguard Group first reported a position in IXHL in Q4 2023 and held it in 1 quarter. The position peaked at $529K in Q4 2023. 13 funds tracked by Wall St. Rank hold IXHL as of Q1 2024.

Vanguard Group reported no remaining Incannex Healthcare position as of Q1 2024 after selling out during the quarter.
Vanguard Group sold 3,802 Incannex Healthcare shares in Q1 2024, an estimated $529K.
Vanguard Group first reported a position in Incannex Healthcare in Q4 2023 and held it in 1 quarter.
Vanguard Group's Incannex Healthcare position peaked at $529K in Q4 2023.
13 funds tracked by Wall St. Rank held Incannex Healthcare as of Q1 2024.

Based on Vanguard Group's 13F filing for Q1 2024, filed 10 May 2024.